查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲內皮功能障礙市場預測至 2028 年 - 區域分析 - 按原因、測試類型和最終用戶
市場調查報告書
商品編碼
1420177

歐洲內皮功能障礙市場預測至 2028 年 - 區域分析 - 按原因、測試類型和最終用戶

Europe Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause, Test Type, and End User
出版日期: | 出版商: The Insight Partners | 英文 122 Pages | 訂單完成後即時交付

價格

歐洲內皮功能障礙市場預計將從2022年的6.1128億美元成長到2028年的7.7637億美元。預計2022年至2028年CAGR為4.1%。

高膽固醇、糖尿病和肥胖發病率上升推動歐洲內皮功能障礙市場

生活型態的改變導致糖尿病、高血壓、血脂異常和肥胖的發生率上升，增加內皮功能障礙的機會。然而，這些可以透過主動監測、早期診斷和身體活動來預防。代謝症候群是一組會增加 CAD、糖尿病、高血壓和其他嚴重健康問題風險的疾病。 2 型糖尿病已經是一個主要的公共衛生問題，並且在與肥胖相關的兒童和年輕人中發病率越來越高。根據世界衛生組織（WHO）的數據，2019年糖尿病是導致150萬人死亡的直接原因，而所有糖尿病死亡人數的48%發生在70歲之前。另有46萬人因腎臟病死亡是由糖尿病引起的。血糖升高導致約 20% 的心血管死亡。

高血壓是全世界心血管疾病和過早死亡的主要原因。根據對人口中高血壓盛行率、檢測、治療和控制趨勢的首次全面全球分析，過去 30 年中，30-79 歲的成年人患有高血壓的人數已從 6.5 億增加到 12.8 億。由倫敦由帝國學院和世界衛生組織制定。

歐洲內皮功能障礙市場概述

歐洲的內皮功能障礙市場細分為英國、德國、義大利、法國、西班牙和歐洲其他地區。心血管疾病盛行率的上升、人口老化的增加以及研發活動的增加是促進該地區市場成長的關鍵因素。此外，產品發布和政府投資將促進預測期內的市場成長。

歐洲內皮功能障礙市場收入及 2028 年預測（百萬美元）

歐洲內皮功能障礙市場細分

歐洲內皮功能障礙市場按原因、測試類型、最終用戶和國家細分。

根據病因，歐洲內皮功能障礙市場分為高血壓、高膽固醇血症、肥胖、糖尿病、白塞氏症等。 2022 年，高血壓細分市場在歐洲內皮功能障礙市佔率最大。

根據測試類型，歐洲內皮功能障礙市場分為侵入性測試和非侵入性測試。到2022 年，侵入性測試細分市場將佔據更大的歐洲內皮功能障礙市場。非侵入性測試細分市場進一步細分為血流介導的擴張、週邊動脈張力測定(PAT)、靜脈閉塞體積描記術、循環標記物等。

根據最終用戶，歐洲內皮功能障礙市場分為醫院、診斷中心、診所等。到 2022 年，醫院細分市場將佔據歐洲最大的內皮功能障礙市場。

根據國家/地區，歐洲內皮功能障礙市場分為英國、德國、義大利、法國、西班牙和歐洲其他地區。德國在 2022 年主導歐洲內皮功能障礙市場。

ZOLL Medical Corp、Sphingo Tec GmbH、The Polymath Co、SMART Medical Ltd、Alam Medical SaRl 和 Medizinische Messtechnik GmbH 是該地區內皮功能障礙市場的一些領先公司。

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 歐洲內皮功能障礙市場 - 按原因分類
    • 歐洲內皮功能障礙市場 - 按測試類型
    • 歐洲內皮功能障礙市場 - 按最終用戶分類
    • 歐洲內皮功能障礙市場 - 按國家/地區

第 2 章：歐洲內皮功能障礙市場 - 要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲內皮功能障礙市場 - 市場格局

  • 概述
  • PEST分析
    • 歐洲PEST分析
  • 專家意見

第 5 章：歐洲內皮功能障礙市場 - 主要市場動態

  • 市場促進因素
    • 心血管疾病發生率增加
    • 高膽固醇、糖尿病和肥胖症的發生率上升
  • 市場限制
    • 內皮功能障礙篩檢技術的缺點
  • 市場機會
    • 新型生物標記和治療策略的使用不斷增加
  • 未來的趨勢
    • 使用非侵入性方法評估內皮功能障礙
  • 影響分析

第 6 章：內皮功能障礙市場 - 歐洲分析

  • 歐洲內皮功能障礙市場收入預測與分析

第 7 章：歐洲內皮功能障礙市場分析 - 按原因

  • 概述
  • 歐洲內皮功能障礙市場，依原因分類，2022 年和 2028 年 (%)
  • 高血壓
  • 糖尿病
  • 高膽固醇血症
  • 白塞氏症
  • 肥胖
  • 其他

第 8 章：歐洲內皮功能障礙市場分析 - 按測試類型

  • 概述
  • 歐洲內皮功能障礙市場，依測試類型，2022 年和 2028 年 (%)
  • 侵入性測試
  • 非侵入性測試

第 9 章：歐洲內皮功能障礙市場分析 - 按最終用戶

  • 概述
  • 歐洲內皮功能障礙市場，依最終使用者分類，2022 年和 2028 年 (%)
  • 醫院
  • 診斷中心
  • 診所
  • 其他

第 10 章：歐洲內皮功能障礙市場 - 收入和 2028 年預測 - 國家分析

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 11 章：歐洲內皮功能障礙市場-產業格局

  • 概述
  • 內皮功能障礙市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • ZOLL Medical Corp
  • Sphingo Tec GmbH
  • The Polymath Co
  • SMART Medical Ltd
  • Alam Medical SaRl
  • Medizinische Messtechnik GmbH

第 13 章：附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: BMIRE00029139

The Europe endothelial dysfunction market is expected to grow from US$ 611.28 million in 2022 to US$ 776.37 million by 2028. It is estimated to grow at a CAGR of 4.1% from 2022 to 2028.

Rising Incidences of High Cholesterol, Diabetes and Obesity Fuels Europe Endothelial Dysfunction Market

Lifestyle changes lead to a rise in the incidences of diabetes, hypertension, dyslipidemia, and obesity, increasing the chances of endothelial dysfunction. However, these can be prevented through proactive monitoring, early diagnosis, and physical activity. Metabolic syndrome is a group of disorders that increases the risk of CAD, diabetes, high blood pressure, and other serious health problems. Type 2 diabetes is already a major public health problem and is increasingly rising among the children and young adults associated with obesity. According to the World Health Organization (WHO), diabetes was the direct cause of 1.5 million deaths in 2019, and 48% of all deaths from diabetes occurred before age 70. Another 460,000 deaths from kidney disease were caused by diabetes. Elevated blood sugar causes ~20% of cardiovascular deaths.

Hypertension is the leading cause of cardiovascular disease and premature death worldwide. The number of adults aged 30-79 with hypertension has increased from 650 million to 1.28 billion over the past 30 years, according to the first comprehensive global analysis of trends in the prevalence, detection, treatment, and control of hypertension among the population, headed by Imperial College London and WHO.

Europe Endothelial Dysfunction Market Overview

The endothelial dysfunction market in Europe is sub-segmented into the UK, Germany, Italy, France, Spain, and the Rest of Europe. The rising prevalence of cardiovascular diseases, an increase in the aging population, and a growing number of research and development activities are the key factors contributing to the market growth in the region. Further, product launches and government investments would facilitate the market growth during the forecast period.

Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Europe Endothelial Dysfunction Market Segmentation

The Europe endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the Europe endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, behcet's disease, and others. The hypertension segment registered the largest Europe endothelial dysfunction market share in 2022.

Based on test type, the Europe endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Europe endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the Europe endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Europe endothelial dysfunction market share in 2022.

Based on country, the Europe endothelial dysfunction market is segmented into the UK, Germany, Italy, France, Spain, and the Rest of Europe. Germany dominated the Europe endothelial dysfunction market in 2022.

ZOLL Medical Corp, Sphingo Tec GmbH, The Polymath Co, SMART Medical Ltd, Alam Medical SaRl, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe endothelial dysfunction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Endothelial Dysfunction Market - by Cause
    • 1.3.2 Europe Endothelial Dysfunction Market - by Test Type
    • 1.3.3 Europe Endothelial Dysfunction Market - by End User
    • 1.3.4 Europe Endothelial Dysfunction Market - by Country

2. Europe Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Endothelial Dysfunction Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis
  • 4.3 Expert Opinion

5. Europe Endothelial Dysfunction Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Cardiovascular Diseases
    • 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
  • 5.2 Market Restraints
    • 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
  • 5.3 Market Opportunities
    • 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
  • 5.4 Future Trends
    • 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
  • 5.5 Impact Analysis

6. Endothelial Dysfunction Market - Europe Analysis

  • 6.1 Europe Endothelial Dysfunction Market Revenue Forecast and Analysis

7. Europe Endothelial Dysfunction Market Analysis - by Cause

  • 7.1 Overview
  • 7.2 Europe Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
  • 7.3 Hypertension
    • 7.3.1 Overview
    • 7.3.2 Hypertension: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Diabetes: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Hypercholestrolaemia
    • 7.5.1 Overview
    • 7.5.2 Hypercholestrolaemia: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Behcet's Disease
    • 7.6.1 Overview
    • 7.6.2 Behcet's Disease: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Obesity
    • 7.7.1 Overview
    • 7.7.2 Obesity: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Endothelial Dysfunction Market Analysis - by Test Type

  • 8.1 Overview
  • 8.2 Europe Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
  • 8.3 Invasive Tests
    • 8.3.1 Overview
    • 8.3.2 Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Non-Invasive Tests
    • 8.4.1 Overview
    • 8.4.2 Non-Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Flow Mediated Dilatory
      • 8.4.3.1 Overview
      • 8.4.3.2 Flow Mediated Dilatory: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.4 Venous Occlusion Plethysmography
      • 8.4.4.1 Overview
      • 8.4.4.2 Venous Occlusion Plethysmography: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.5 Peripheral Arterial Tonometry (PAT)
      • 8.4.5.1 Overview
      • 8.4.5.2 Peripheral Arterial Tonometry (PAT): Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Circulating Markers
      • 8.4.6.1 Overview
      • 8.4.6.2 Circulating Markers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.7 Others
      • 8.4.7.1 Overview
      • 8.4.7.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Endothelial Dysfunction Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Europe Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Diagnostics Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostics Centers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Clinics
    • 9.5.1 Overview
    • 9.5.2 Clinics: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Europe: Endothelial Dysfunction Market
    • 10.1.1 Overview
      • 10.1.1.1 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 Germany: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.1.4 Germany: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.1.4.1 Germany: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.5 Germany: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 UK: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.2.4 UK: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.2.4.1 UK: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.5 UK: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.3 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 France: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.3.4 France: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.3.4.1 France: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.5 France: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.4 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Italy: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.4.4 Italy: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.4.4.1 Italy: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.5 Italy: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.5 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 Spain: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.5.4 Spain: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.5.4.1 Spain: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.5 Spain: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.6 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
        • 10.1.1.6.4.1 Rest of Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Europe Endothelial Dysfunction Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Endothelial Dysfunction Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 ZOLL Medical Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sphingo Tec GmbH
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 The Polymath Co
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 SMART Medical Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Alam Medical SaRl
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Medizinische Messtechnik GmbH
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Techniques Used in to Assess Endothelial Function
  • Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
  • Table 3. Germany Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Germany Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Germany Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Germany Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. UK Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. UK Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. UK Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. UK Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. France Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. France Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. France Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. France Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Italy Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Italy Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Italy Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Italy Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Spain Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Spain Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Spain Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Spain Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Rest of Europe Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Rest of Europe Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Rest of Europe Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Rest of Europe Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
  • Table 28. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
  • Table 29. Glossary of Terms, Endothelial dysfunction market

List Of Figures

  • Figure 1. Europe Endothelial Dysfunction Market Segmentation
  • Figure 2. Europe Endothelial Dysfunction Market, by Country
  • Figure 3. Europe Endothelial Dysfunction Market Overview
  • Figure 4. Hypertension Account for Largest Share of Cause Segment in Europe Endothelial Dysfunction Market
  • Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Europe: PEST Analysis
  • Figure 7. Expert Opinion
  • Figure 8. Europe Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
  • Figure 9. Europe Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Europe Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
  • Figure 11. Hypertension: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Diabetes: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Hypercholestrolaemia: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Behcet's disease: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Obesity: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Europe Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
  • Figure 18. Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Non-Invasive Tests: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Flow Mediated Dilatory: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Venous Occlusion Plethysmography: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Peripheral Arterial Tonometry (PAT): Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Circulating Markers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Europe Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
  • Figure 26. Hospitals and Clinics: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Diagnostics Centers: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Clinics: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Others: Europe Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Europe: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Europe: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
  • Figure 32. Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. UK: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. France: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Growth Strategies in the Endothelial Dysfunction Market